In one of the most significant milestones for depression treatment in decades, the U.S. Food and Drug Administration announced today that it has approved a new drug with esketamine, a derivative of ketamine. Made by Johnson & Johnson under the brand name Spravato, the drug is meant to be taken as a nasal spray in […]
View More FDA approves esketamine nasal spray, the first new major depression drug in more than 30 yearsKnowledge is POWER